BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05287113-completion@plaintrial.com
DTSTAMP:20261028T231050Z
DTSTART;VALUE=DATE:20260710
SUMMARY:Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02
 390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1
 ) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck — es
 timated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05287113
URL:https://plaintrial.com/trial/NCT05287113
END:VEVENT
END:VCALENDAR